Sales of „Olainfarm” in Eleven Months Increase by 17%

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sales of „Olainfarm” in Eleven Months Increase by 17%

Olaine, 2014-12-15 15:54 CET (GLOBE NEWSWIRE) --  

November 2014, consolidated sales Share in total sales Changes to November 2013
Russia 35% -28%
Latvia 26% 5%
The Netherlands 11% 227%
Belarus 9% 6%
Ukraine 8% -81%
Kazakhstan 4% -11%
Uzbekistan 2% 51%
Lithuania 2% 94%
Tajikistan 1% -42%
Moldova 1% -28%
Other 2% -35%
Total 100% -27%

Sales of pharmacy chain of SIA „Latvijas Aptieka”, fully owned by AS “Olainfarm” during this period were 1.3 million euro, and the chain consisted of 57 operating pharmacies. Sales of SIA „Silvanols” in this period were 0.29 million euro, and the sales were made to four European companies.

According to preliminary consolidated figures, during eleven months of 2014, AS “Olainfarm” made sales worth 84.77 million euro, which represents an increase by 17% compared to the same period of 2013.  The most rapid sales increases during this period were achieved in Poland, where sales grew by 378%, sales to The Netherlands grew by 170% and sales to Lithuania grew by 56%.  The major sales markets of AS “Olainfarm” during 11 months of 2014 were Russia, Latvia, Ukraine and Belarus.

11 months of 2014, consolidated sales Share in total sales Changes to 11 months of 2013
Russia 37% 13%
Latvia 23% 17%
Ukraine 13% 23%
Belarus 8% 22%
The Netherlands 3% 170%
Kazakhstan 3% -22%
UK       2% -32%
Poland 2% 378%
Uzbekistan 2% -3%
Lithuania 1% 56%
Other 8% 18%
Total 100% 17%

Sales of pharmacy chain of SIA „Latvijas Aptieka”, fully owned by AS “Olainfarm” during 11 months were 13.8 million euro. Sales of SIA „Silvanols” in 11 months period were 3.07 million euro, and the sales were made to ten European companies.

According to preliminary unconsolidated results of AS “Olainfarm” for November of 2014, company’s sales have reached 5.79 million euro, which represents a reduction by 13% compared to the same period one year ago. The biggest sales increases were achieved in The Netherlands, where sales grew by 227%, and sales to Lithuania have grown by 156%, while sales to Uzbekistan have grown by 51%.  Sales to Latvia have grown by 36%.    The major sales markets of AS “Olainfarm” in November 2014 were Russia, Latvia, The Netherlands and Belarus. In November 2014 AS „Olainfarm” made sales to 19 countries on 3 continents

November 2014 unconsolidated results Share in total sales Changes to November 2013
Russia 40% -28%
Latvia 15% 36%
The Netherlands 11% 227%
Belarus 9% 6%
Ukraine 9% -81%
Kazakhstan 4% -11%
Uzbekistan 2% 51%
Lithuania 2% 156%
Tajikistan 1% -42%
Moldova 1% -28%
Other 2% -16%
Total 100% -13%

According to preliminary unconsolidated figures, during eleven months of 2014, AS “Olainfarm” made sales worth 73.58 million euro, which represents an increase by 21% compared to the same period of 2013.  The most rapid sales increases during this period were achieved in Poland, where sales grew by 1013%, sales to The Netherlands grew by 170% and sales to Tajikistan grew by 58%.  Sales to Latvia grew by 34% According to preliminary unconsolidated sales figures, the major markets of AS “Olainfarm” during 11 months of 2014 were Russia, Ukraine, Latvia and Belarus. During eleven months of 2014 the sales were made to 35 countries on five continents

.

11 months of 2014, unconsolidated sales Share in total sales Changes to 11 months of 2013
Russia 43% 13%
Ukraine 15% 23%
Latvia 12% 34%
Belarus 9% 22%
The Netherlands 3% 170%
Kazakhstan 3% -22%
UK 2% -32%
Uzbekistan 2% -3%
Poland 2% 1013%
Tajikistan 1% 58%
Other 8% 14%
Total 100% 21%

On April 29, 2014 an AGM of AS “Olainfarm” approved an operating plan of the company, providing that the unconsolidated sales target for 2014 is 80 million euro, while consolidated sales target for 2014 is 93 million euro.  According to these preliminary sales results, in eleven months of 2014 AS „Olainfarm” has met 92% on annual unconsolidated sales target and 91% of annual consolidated sales target. 

 JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia

         Information prepared by:                    Salvis Lapins          JSC “Olainfarm”          Member of the Management Board          Rupnicu iela 5, Olaine, Latvia, LV 2114          Phone: +371 6 7013 717          Fax: +371 6 7013 777          E-mail: Salvis.Lapins@olainfarm.lv

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Mavis Discount Tire Launches New Premier Facility in Florida

Updated Category News Views 119

Mavis Discount Tire Launches New Premier Facility in Florida Mavis Discount Tire, known for its superior automotive service and commitment to customer satisfaction, is thrilled to announce the opening of its latest facility. The new store location, situated at 5260 US Hwy 1, is designed to cater to the needs of the Harris Point and nearby community. Expanding Presence and...

Continue Reading
Electra Therapeutics Secures Major Funding for Innovative Cancer Therapies

Updated Category News Views 250

Electra Therapeutics Makes a Significant Funding Leap Electra Therapeutics has recently announced a remarkable $183 million Series C financing round aimed at enhancing its pipeline of innovative therapies designed to tackle immune disorders and various cancers. This substantial funding is not only indicative of the investors' confidence in the company but also emphasizes...

Continue Reading
Transforming Business Culture: A Call for Excellence

Updated Category News Views 92

Transforming Business Culture: A Call for Excellence In today's dynamic corporate landscape, where competition is fierce and expectations are high, settling for mediocrity is not an option. Bestselling author and leadership expert John Rossman has articulated this challenge in his new work, “The Pig, The Lipstick and the Three Pillars of Champions: Reclaiming Your...

Continue Reading
Quantum BioPharma Offers $7 Million Reward for Insider Tips

Updated Category News Views 130

Quantum BioPharma Announces Whistleblower Cash Reward Quantum BioPharma Ltd. (NASDAQ: QNTM) is making significant waves in the biopharmaceutical industry with its innovative strategy designed to combat stock manipulation. The company has launched a whistleblower policy that offers a remarkable cash reward of up to USD $7 million to those who provide concrete evidence...

Continue Reading
Evaxion Biotech Prepares for Upcoming Quarterly Earnings Call

Updated Category News Views 142

Anticipating Evaxion Biotech's Quarterly Earnings Evaxion Biotech (NASDAQ: EVAX) is gearing up to unveil its quarterly earnings report, creating a buzz of anticipation among investors. The company aims to share essential financial details that could influence stock performance and investor sentiment. Expected Earnings Performance Analyst Predictions Analysts predict that...

Continue Reading